110 related articles for article (PubMed ID: 8233626)
21. Numerical taxonomy of staphylococci.
Goodfellow M; Alderson G; Nahaie MR; Peters G; Schumacher-Perdreau F; Pulverer G; Heczko PB; Mordarski M
Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Nov; 256(1):7-24. PubMed ID: 6659744
[TBL] [Abstract][Full Text] [Related]
22. Coagulase-negative staphylococci in air samples from operating theatres.
Kiss L; Sztroj T; Széll M
Acta Microbiol Immunol Hung; 1996; 43(1):39-46. PubMed ID: 8806942
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the antimicrobial susceptibilities of coagulase-negative staphylococci by E-test.
Barelli C; Minto EC; Martinez R; Darini AL
Rev Latinoam Microbiol; 1999; 41(2):67-72. PubMed ID: 10932753
[TBL] [Abstract][Full Text] [Related]
24. Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology.
Boisson K; Thouverez M; Talon D; Bertrand X
Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):660-5. PubMed ID: 12373498
[TBL] [Abstract][Full Text] [Related]
25. [Characteristics of coagulase-negative staphylococci isolated from hemocultures].
Drozenová J; Petrás P
Epidemiol Mikrobiol Imunol; 2000 Apr; 49(2):51-8. PubMed ID: 10838776
[TBL] [Abstract][Full Text] [Related]
26. Identification of coagulase-negative staphylococci other than Staphylococcus epidermidis by automated ribotyping.
Carretto E; Barbarini D; Couto I; De Vitis D; Marone P; Verhoef J; De Lencastre H; Brisse S
Clin Microbiol Infect; 2005 Mar; 11(3):177-84. PubMed ID: 15715714
[TBL] [Abstract][Full Text] [Related]
27. Methicillin resistance of airborne coagulase-negative staphylococci in homes of persons having contact with a hospital environment.
Lis DO; Pacha JZ; Idzik D
Am J Infect Control; 2009 Apr; 37(3):177-82. PubMed ID: 19155097
[TBL] [Abstract][Full Text] [Related]
28. Polynucleotide sequence divergence among some coagulase-negative staphylococci.
Goodfellow M; Mordarski M; Tkacz A; Szyba K; Pulverer G
Zentralbl Bakteriol A; 1980 Feb; 246(1):10-22. PubMed ID: 7424234
[TBL] [Abstract][Full Text] [Related]
29. Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods.
Mushtaq S; Warner M; Johnson AP; Livermore DM
J Antimicrob Chemother; 2004 Sep; 54(3):617-20. PubMed ID: 15321983
[TBL] [Abstract][Full Text] [Related]
30. Simple and economical method for speciation and resistotyping of clinically significant coagulase negative staphylococci.
Goyal R; Singh NP; Kumar A; Kaur I; Singh M; Sunita N; Mathur M
Indian J Med Microbiol; 2006 Jul; 24(3):201-4. PubMed ID: 16912440
[TBL] [Abstract][Full Text] [Related]
31. The effectiveness of lysostaphin therapy for experimental coagulase-negative Staphylococcus endophthalmitis.
McCormick CC; Dajcs JJ; Reed JM; Marquart ME; O'Callaghan RJ
Curr Eye Res; 2006 Mar; 31(3):225-30. PubMed ID: 16531279
[TBL] [Abstract][Full Text] [Related]
32. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of ramoplanin on staphylococci.
Francis J; Webster H; Newsom SW
Drugs Exp Clin Res; 1990; 16(9):457-60. PubMed ID: 2100247
[TBL] [Abstract][Full Text] [Related]
34. Relationship between slime production, antibiotic sensitivity and the phagetype of coagulase-negative staphylococci.
Boussard P; Pithsy A; Devleeschouwer MJ
J Clin Pharm Ther; 1993 Aug; 18(4):271-4. PubMed ID: 8227235
[TBL] [Abstract][Full Text] [Related]
35. Cellular fatty acid composition in staphylococci isolated from bovine milk.
Sincoweay H; Miyagawa E; Kume T
Natl Inst Anim Health Q (Tokyo); 1981; 21(1):14-20. PubMed ID: 7242689
[TBL] [Abstract][Full Text] [Related]
36. [Differentiation of staphylococci from sheep and goat milk samples].
Deinhofer M; Pernthaner A
Dtsch Tierarztl Wochenschr; 1993 Jun; 100(6):234-6. PubMed ID: 8339709
[TBL] [Abstract][Full Text] [Related]
37. Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007).
Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):177-84. PubMed ID: 19249179
[TBL] [Abstract][Full Text] [Related]
38. Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci.
Goldstein FW; Coutrot A; Sieffer A; Acar JF
Antimicrob Agents Chemother; 1990 May; 34(5):899-900. PubMed ID: 2141780
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of induction L-form of Staphylococcus epidermidis, Staphylococcus haemolyticus by cefazolin].
Wróblewska J; Gospodarek E; Sekowska A; Mikołajczyk D; Janicka G
Pol Merkur Lekarski; 2008 Dec; 25(150):500-2. PubMed ID: 19205381
[TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
Kuti JL; Kiffer CR; Mendes CM; Nicolau DP
Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
